{"pmid":32426558,"pmcid":"PMC7230145","title":"Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against \"SARS-CoV-2 nephropathy\".","text":["Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against \"SARS-CoV-2 nephropathy\".","Kidney Int Rep","Rossi, Giovanni Maria","Delsante, Marco","Pilato, Francesco Paolo","Gnetti, Letizia","Gabrielli, Liliana","Rossini, Giada","Re, Maria Carla","Cenacchi, Giovanna","Affanni, Paola","Colucci, Maria Eugenia","Picetti, Edoardo","Rossi, Sandra","Parenti, Elisabetta","Maccari, Caterina","Greco, Paolo","Di Mario, Francesca","Maggiore, Umberto","Regolisti, Giuseppe","Fiaccadori, Enrico","32426558"],"journal":"Kidney Int Rep","authors":["Rossi, Giovanni Maria","Delsante, Marco","Pilato, Francesco Paolo","Gnetti, Letizia","Gabrielli, Liliana","Rossini, Giada","Re, Maria Carla","Cenacchi, Giovanna","Affanni, Paola","Colucci, Maria Eugenia","Picetti, Edoardo","Rossi, Sandra","Parenti, Elisabetta","Maccari, Caterina","Greco, Paolo","Di Mario, Francesca","Maggiore, Umberto","Regolisti, Giuseppe","Fiaccadori, Enrico"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426558","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ekir.2020.05.005","keywords":["aki","covid-19","rrt","sars-cov-2 nephropathy","sled","intensive care unit"],"topics":["Case Report"],"weight":1,"_version_":1667352728759697408,"score":9.490897,"similar":[{"pmid":32416116,"title":"ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19.","text":["ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19.","The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted with Covid-19, AKI developed in 1,993 (36.6%). The peak stages of AKI were stage 1 in 46.5%, stage 2 in 22.4% and stage 3 in 31.1%. Of these, 14.3% required renal replacement therapy (RRT). AKI was primarily seen in Covid-19 patients with respiratory failure, with 89.7% of patients on mechanical ventilation developing AKI compared to 21.7% of non-ventilated patients. 276/285 (96.8%) of patients requiring RRT were on ventilators. Of patients who required ventilation and developed AKI, 52.2% had the onset of AKI within 24 hours of intubation. Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Among patients with AKI, 694 died (35%), 519 (26%) were discharged and 780 (39%) were still hospitalized. AKI occurs frequently among patients with Covid-19 disease. It occurs early and in temporal association with respiratory failure and is associated with a poor prognosis.","Kidney Int","Hirsch, Jamie S","Ng, Jia H","Ross, Daniel W","Sharma, Purva","Shah, Hitesh H","Barnett, Richard L","Hazzan, Azzour D","Fishbane, Steven","Jhaveri, Kenar D","32416116"],"abstract":["The rate of acute kidney injury (AKI) associated with patients hospitalized with Covid-19, and associated outcomes are not well understood. This study describes the presentation, risk factors and outcomes of AKI in patients hospitalized with Covid-19. We reviewed the health records for all patients hospitalized with Covid-19 between March 1, and April 5, 2020, at 13 academic and community hospitals in metropolitan New York. Patients younger than 18 years of age, with end stage kidney disease or with a kidney transplant were excluded. AKI was defined according to KDIGO criteria. Of 5,449 patients admitted with Covid-19, AKI developed in 1,993 (36.6%). The peak stages of AKI were stage 1 in 46.5%, stage 2 in 22.4% and stage 3 in 31.1%. Of these, 14.3% required renal replacement therapy (RRT). AKI was primarily seen in Covid-19 patients with respiratory failure, with 89.7% of patients on mechanical ventilation developing AKI compared to 21.7% of non-ventilated patients. 276/285 (96.8%) of patients requiring RRT were on ventilators. Of patients who required ventilation and developed AKI, 52.2% had the onset of AKI within 24 hours of intubation. Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Among patients with AKI, 694 died (35%), 519 (26%) were discharged and 780 (39%) were still hospitalized. AKI occurs frequently among patients with Covid-19 disease. It occurs early and in temporal association with respiratory failure and is associated with a poor prognosis."],"journal":"Kidney Int","authors":["Hirsch, Jamie S","Ng, Jia H","Ross, Daniel W","Sharma, Purva","Shah, Hitesh H","Barnett, Richard L","Hazzan, Azzour D","Fishbane, Steven","Jhaveri, Kenar D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416116","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.kint.2020.05.006","keywords":["aki","covid-19","crrt","dialysis","renal failure"],"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666994545963827200,"score":107.128456},{"pmid":32438617,"title":"A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19.","text":["A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19.","COVID-19 often leads to acute respiratory distress syndrome complicated by acute kidney injury (AKI). The indications for renal replacement therapy for these patients are those commonly accepted to treat AKI. We describe a continuous veno-venous haemodialysis (CVVHD) protocol for AKI, which aims to provide the best treatment according to the particular patient's and medical personnels' needs in biohazard settings with limited human and technological resources. We designed a CVVHD protocol with a high cut-off (HCO) filter in regional citrate anticoagulation (RCA). The HCO filter in diffusion determines the enhanced cytokines clearance with less filter clotting due to a lower filtration fraction. In our hospital, at the beginning of the pandemic outbreak, we treated seven COVID-19 patients with AKI stage 2 and 3 and recorded the circuit lifespan and the number of interventions on monitors. CVVHD in RCA appears to be safe, effective and easy to be performed in a biohazard scenario using lower blood flows and less bag changes with fluid savings, a biohazard reduction and sparing of resources. Although the data come from a very small cohort, our protocol seems related to a low mortality.","J Clin Med","Nalesso, Federico","Garzotto, Francesco","Cattarin, Leda","Gobbi, Laura","Qassim, Laila","Sgarabotto, Luca","Tiberio, Ivo","Calo, Lorenzo A","32438617"],"abstract":["COVID-19 often leads to acute respiratory distress syndrome complicated by acute kidney injury (AKI). The indications for renal replacement therapy for these patients are those commonly accepted to treat AKI. We describe a continuous veno-venous haemodialysis (CVVHD) protocol for AKI, which aims to provide the best treatment according to the particular patient's and medical personnels' needs in biohazard settings with limited human and technological resources. We designed a CVVHD protocol with a high cut-off (HCO) filter in regional citrate anticoagulation (RCA). The HCO filter in diffusion determines the enhanced cytokines clearance with less filter clotting due to a lower filtration fraction. In our hospital, at the beginning of the pandemic outbreak, we treated seven COVID-19 patients with AKI stage 2 and 3 and recorded the circuit lifespan and the number of interventions on monitors. CVVHD in RCA appears to be safe, effective and easy to be performed in a biohazard scenario using lower blood flows and less bag changes with fluid savings, a biohazard reduction and sparing of resources. Although the data come from a very small cohort, our protocol seems related to a low mortality."],"journal":"J Clin Med","authors":["Nalesso, Federico","Garzotto, Francesco","Cattarin, Leda","Gobbi, Laura","Qassim, Laila","Sgarabotto, Luca","Tiberio, Ivo","Calo, Lorenzo A"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32438617","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3390/jcm9051529","keywords":["aki","ards","crrt","cvvhd","covid-19","hco","cytokines","intensive care"],"e_drugs":["Citric Acid"],"topics":["Treatment"],"weight":1,"_version_":1667523504871833602,"score":91.64302},{"pmid":32371056,"title":"Care of critically ill pregnant patients with COVID-19: a case series.","text":["Care of critically ill pregnant patients with COVID-19: a case series.","Am J Obstet Gynecol","Hirshberg, Adi","Kern-Goldberger, Adina R","Levine, Lisa D","Pierce-Williams, Rebecca","Short, William R","Parry, Samuel","Berghella, Vincenzo","Triebwasser, Jourdan E","Srinivas, Sindhu K","32371056"],"journal":"Am J Obstet Gynecol","authors":["Hirshberg, Adi","Kern-Goldberger, Adina R","Levine, Lisa D","Pierce-Williams, Rebecca","Short, William R","Parry, Samuel","Berghella, Vincenzo","Triebwasser, Jourdan E","Srinivas, Sindhu K"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371056","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ajog.2020.04.029","keywords":["covid-19","coronavirus","critical care","intensive care unit","maternal morbidity","maternal mortality","mechanical ventilation"],"topics":["Case Report"],"weight":1,"_version_":1666138496441516034,"score":78.78722},{"pmid":32405454,"pmcid":"PMC7219375","title":"Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran.","text":["Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran.","We reported a 33-year-old female case with novel coronavirus disease 2019 (COVID-19) accompanied by Acute tubular necrosis (ATN). She had a gestational age of 34 weeks. The patient referred to treatment clinic for COVID-19 in Imam Reza hospital of Tabriz (Iran) after having flu-like symptoms. In radiologic assessment, ground glass opacity (GGO) with consolidation was found in upper right lobe. Lopinavir/ritonavir (200mg/50mg) two tablet tow times, Ribavirin 200mg every six hours, and Oseltamivir 75mg tow times were given for the treatment of COVID-19. The medications used for treatment of pneumonia were Meropenem, Ciprofloxacin, Vancomycin. All doses of medications were administrated by adjusted dose assuming the patient is anephric. Also, a few supplements were also given after ATN development including daily Rocaltrol and Nephrovit (as a multivitamin appropriate for patients with renal failure), Folic acid and Calcium carbonate. The patient is still under ventilator with a Fraction of inspired oxygen (FiO2) of 60% and Positive end-expiratory pressure (PEEP) of eight. SpO2 is 94% but the patient's ATN problem has been resolved. We started weaning from mechanical ventilator. The patient is conscious with full awareness to time, person and place. The maternal well-being is achieved and her neonate was discharged.","Respir Med Case Rep","Taghizadieh, Ali","Mikaeili, Haleh","Ahmadi, Majid","Valizadeh, Hamed","32405454"],"abstract":["We reported a 33-year-old female case with novel coronavirus disease 2019 (COVID-19) accompanied by Acute tubular necrosis (ATN). She had a gestational age of 34 weeks. The patient referred to treatment clinic for COVID-19 in Imam Reza hospital of Tabriz (Iran) after having flu-like symptoms. In radiologic assessment, ground glass opacity (GGO) with consolidation was found in upper right lobe. Lopinavir/ritonavir (200mg/50mg) two tablet tow times, Ribavirin 200mg every six hours, and Oseltamivir 75mg tow times were given for the treatment of COVID-19. The medications used for treatment of pneumonia were Meropenem, Ciprofloxacin, Vancomycin. All doses of medications were administrated by adjusted dose assuming the patient is anephric. Also, a few supplements were also given after ATN development including daily Rocaltrol and Nephrovit (as a multivitamin appropriate for patients with renal failure), Folic acid and Calcium carbonate. The patient is still under ventilator with a Fraction of inspired oxygen (FiO2) of 60% and Positive end-expiratory pressure (PEEP) of eight. SpO2 is 94% but the patient's ATN problem has been resolved. We started weaning from mechanical ventilator. The patient is conscious with full awareness to time, person and place. The maternal well-being is achieved and her neonate was discharged."],"journal":"Respir Med Case Rep","authors":["Taghizadieh, Ali","Mikaeili, Haleh","Ahmadi, Majid","Valizadeh, Hamed"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405454","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.rmcr.2020.101090","keywords":["atn","infection","kidney","pregnancy","renal involvement","sars-cov-2"],"locations":["Acute","Tabriz","Iran","Meropenem","Ciprofloxacin","Vancomycin","Nephrovit","Iran"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"e_drugs":["Calcitriol","Ciprofloxacin","Oseltamivir","Ribavirin","Vancomycin","Folic Acid","Calcium Carbonate","Meropenem","lopinavir-ritonavir drug combination"],"topics":["Case Report"],"weight":1,"_version_":1666802845291118592,"score":67.498505},{"pmid":32402156,"title":"Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.","text":["Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.","N Engl J Med","Sise, Meghan E","Baggett, Meridale V","Shepard, Jo-Anne O","Stevens, Jacob S","Rhee, Eugene P","32402156"],"journal":"N Engl J Med","authors":["Sise, Meghan E","Baggett, Meridale V","Shepard, Jo-Anne O","Stevens, Jacob S","Rhee, Eugene P"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32402156","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1056/NEJMcpc2002418","topics":["Case Report"],"weight":1,"_version_":1666714494920818689,"score":66.37034}]}